Consumer goods powerhouse Procter & Gamble (PG +2.46%) reported fiscal year 2025 second-quarter earnings on Wednesday, Jan. 22, that topped analyst consensus estimates. Core earnings per share (EPS) came in at $1.88 over the anticipated $1.86 while revenue reached $21.9 billion, exceeding projections by $400 million and improving by 2.3% from the second quarter of 2024.
Procter & Gamble displayed solid financial metrics, though challenges, such as high supply chain costs, remain a point of concern.
| Metric | Q2 2025 | Analysts' Estimate | Q2 2024 | Change (YOY) |
|---|---|---|---|---|
| Core EPS | $1.88 | $1.86 | $1.84 | 2.2% |
| Revenue | $21.9 billion | $21.5 billion | $21.4 billion | 2.3% |
| Operating income | $5.74 billion | N/A | $4.43 billion | 29.5% |
| Net earnings | $4.66 billion | N/A | $3.49 billion | 33.3% |
| Adj. free cash flow | $3.9 billion | N/A | $4.3 billion | (9%) |
Source: Procter & Gamble. Note: Analyst consensus estimates for the quarter provided by FactSet. YOY = Year over year.
Procter & Gamble operates a vast global consumer goods business, offering products in categories including Beauty, Grooming, Health Care, and Home Care. With a footprint in approximately 180 countries, it leverages significant market presence and established partnerships with key retailers like Walmart. Its business thrives on continual innovation and brand superiority, ensuring product competitiveness amidst diverse consumer demands.
Recently, the company has focused on sustaining product superiority and enhancing brand communication. Key success factors for Procter & Gamble include maintaining strong retailer relationships, emphasizing research-driven innovation, and ensuring efficient supply chain management.
Quarterly Highlights
During the second quarter of fiscal year 2025, Procter & Gamble noted a 3% growth in organic sales, attributed to a 2% rise in organic volume. Pricing remained stable without a significant impact on revenue. Detailed segment analyses highlighted varied performances across categories.
Within the Beauty segment, organic sales grew by 2% as gains in Personal Care offset declines in premium SK-II brands. The Grooming category increased sales by 2% driven by innovative products. Health Care saw a 3% rise, supported by consumer demand for oral health products. Fabric & Home Care climbed 3%, with North America contributing steady volume growth. The Baby, Feminine & Family Care segment excelled, reporting a 4% increase, largely due to strong growth in Family Care.
NYSE: PG
Key Data Points
Financial metrics underscored Procter & Gamble's robust standing despite challenging conditions. Operating margin improved by 550 basis points due to prior-year adjustments, although challenges with cost pressures slightly lowered the core operating margin by 80 basis points. Cash flow was healthy, with an operating cash flow of $4.8 billion and substantial returns to shareholders totaling $4.9 billion through dividends and share repurchases.
Regionally, challenges emerged in Asia, specifically Greater China, where sales declined by 15% due to market conditions and brand-specific issues. Management emphasized agility and ongoing focus on strategic innovation to navigate these complexities.
The quarter observed no significant one-time events, except for ongoing restructuring in select markets, impacting primarily Argentina and Nigeria. Dividend policy remained stable, with plans to return $16 billion-$17 billion to shareholders in fiscal 2025.
Looking Ahead
Procter & Gamble's management remains optimistic about future performance, maintaining its fiscal 2025 guidance. The company anticipates sales growth between 2% to 4% and organic sales growth from 3% to 5%. For core EPS, expectations are in the range of $6.91 to $7.05 per share, slightly outpacing previous year figures.
Investors are encouraged to monitor cost management strategies, particularly in the context of commodity prices and supply chain efficiencies. Management remains committed to delivering comprehensive consumer value and innovation, continuing its strategic investments in product development and geographic market expansion.
